Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.53 |
| ▸ | CA2 | P00918 | 4/20 | 0.53 |
| ▸ | CA9 | Q16790 | 3/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.53 |
| ▸ | CA3 | P07451 | 1/20 | 0.53 |
| ▸ | CA4 | P22748 | 1/20 | 0.53 |
| ▸ | CA6 | P23280 | 1/20 | 0.53 |
| ▸ | CA5A | P35218 | 1/20 | 0.53 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | HBB | P68871 | 1/20 | 0.39 |
| ▸ | KDM5A | P29375 | 1/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29580952 | 1.00 | CA12 (0.53) | CA12CA2CA9CA14CA3 | |
| SCHEMBL29580954 | 1.00 | CA12 (0.53) | CA12CA2CA9CA14CA3 | |
| SCHEMBL129815 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL22771623 | 0.92 | — | — | |
| SCHEMBL27554512 | 0.92 | — | — | |
| Ammonia Solution, Strong SCHEMBL9405419 | 0.92 | — | — | |
| Water SCHEMBL27802509 | 0.92 | — | — | |
| SCHEMBL10085021 | 0.89 | CA12 (0.44) | CA12CA2CA9CA14CA3 | |
| SCHEMBL6923407 | 0.89 | CA12 (0.73) | CA12CA2CA9CA14CA3 | |
| SCHEMBL12929089 | 0.89 | CA12 (0.73) | CA12CA2CA9CA14CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7030257-B2 | Metallocenes and processes for their preparation | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2006-04-18 | — | — | US | claimed |
| US-20050228189-A1 | Novel metallocenes and processes for their preparation | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2005-10-13 | — | — | US | claimed |
| WO-2024112744-A1 | CATALYSTS AND METHODS OF USE THEREOF | YALE UNIVERSITY (US) | 2024-05-30 | — | — | WO | disclosed |
| WO-2023117421-A1 | PAINTS CONTAINING DRIERS BASED ON VANADIUM COMPOUNDS BEARING VARIOUS ACID ANIONS | BORCHERS GMBH (DE) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023061405-A1 | HIGHLY-STABLE TARGETED LINKER-DRUG CONJUGATE | 成都科岭源医药技术有限公司 | 2023-04-20 | — | — | WO | disclosed |
| US-20170216445-A1 | CXCR4 INHIBITING CARRIERS FOR NUCLEIC ACID DELIVERY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-08-03 | — | — | US | disclosed |
| US-9545453-B2 | CXCR4 inhibiting carriers for nucleic acid delivery | WAYNE STATE UNIVERSITY (US) | 2017-01-17 | — | — | US | disclosed |
| US-9545453-B2 | CXCR4 inhibiting carriers for nucleic acid delivery | WAYNE STATE UNIVERSITY (US) | 2017-01-17 | — | — | US | disclosed |
| US-20160169850-A1 | SENSOR MOLECULE | UNIV MALTA (MT) | 2016-06-16 | — | — | US | disclosed |
| US-20160115038-A1 | METHOD FOR MAKING MOLECULAR SIEVE SSZ-102 | CHEVRON U.S.A. INC (US) | 2016-04-28 | — | — | US | disclosed |
| US-20150196032-A1 | ANTIVIRAL COMPOSITIONS | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2015-07-16 | — | — | US | disclosed |
| US-8772446-B2 | Bifunctional chelating agents | NORDION (CANADA) INC. (CA) | 2014-07-08 | — | — | US | disclosed |
| WO-2013056250-A2 | CXCR4 INHIBITING CARRIERS FOR NUCLEIC ACID DELIVERY | WAYNE STATE UNIVERSITY (US) | 2013-04-18 | — | — | WO | disclosed |
| US-20110313130-A1 | BIFUNCTIONAL CHELATING AGENTS | NORDION (CANADA) INC. | 2011-12-22 | — | — | US | disclosed |
| US-7879861-B2 | 4-N-(3-bromophenyl)-6-N-(2-chloroethyl)quinazoline-4,6-diamine, capable of both inhibiting epidermal growth factor receptors and damaging DNA; antitumor and antiproliferative agents | MCGILL UNIVERSITY (CA) | 2011-02-01 | — | — | US | disclosed |
| US-7879861-B2 | 4-N-(3-bromophenyl)-6-N-(2-chloroethyl)quinazoline-4,6-diamine, capable of both inhibiting epidermal growth factor receptors and damaging DNA; antitumor and antiproliferative agents | MCGILL UNIVERSITY (CA) | 2011-02-01 | — | — | US | disclosed |
| EP-1735325-A1 | STABLE HIGH OXIDATION STATE DIAMINE METALLOCENES AND PROCESSES FOR THEIR PREPARATION | Agency for Science, Technology and Research (SG) | 2006-12-27 | — | — | EP | disclosed |
| US-7030257-B2 | Metallocenes and processes for their preparation | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2006-04-18 | — | — | US | disclosed |
| WO-2005100372-A1 | STABLE HIGH OXIDATION STATE DIAMINE METALLOCENES AND PROCESSES FOR THEIR PREPARATION | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2005-10-27 | — | — | WO | disclosed |
| US-20050228189-A1 | Novel metallocenes and processes for their preparation | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2005-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313130-A1 | BIFUNCTIONAL CHELATING AGENTS | FCGRT, C1QBP, H1-2 | CA12 49/4885CA2 166/4885CA9 285/4885 |
| US-20050228189-A1 | Novel metallocenes and processes for their preparation | SOD1, GPX4, NOX4 | CA12 1003/4885CA2 3551/4885CA9 2519/4885 |
| US-20160169850-A1 | SENSOR MOLECULE | QSOX1, AOX1, SCO2 | CA12 526/4885CA2 124/4885CA9 942/4885 |
| US-20170216445-A1 | CXCR4 INHIBITING CARRIERS FOR NUCLEIC ACID DELIVERY | CXCL12, CXCR4, CXCR2 | CA12 3135/4885CA2 2835/4885CA9 1910/4885 |
| US-20150196032-A1 | ANTIVIRAL COMPOSITIONS | EIF2AK2, MAVS, SARS1 | CA12 2623/4885CA2 3759/4885CA9 2600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.